Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?

Background: The 2024-revised McDonald criteria for multiple sclerosis (MS) proposed to incorporate cerebrospinal fluid (CSF)-specific oligoclonal bands and kappa free light chains (KFLC) as diagnostic biomarkers. While the 2017-revised criteria highlighted CSF-specific oligoclonal bands to indicate...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Konen, Franz Felix (VerfasserIn) , Wurster, Ulrich (VerfasserIn) , Schwenkenbecher, Philipp (VerfasserIn) , Gerritzen, Andreas (VerfasserIn) , Groß, Catharina Christiane (VerfasserIn) , Eichhorn, Peter (VerfasserIn) , Harrer, Andrea (VerfasserIn) , Isenmann, Stefan (VerfasserIn) , Lewczuk, Piotr (VerfasserIn) , Lewerenz, Jan (VerfasserIn) , Leypoldt, Frank (VerfasserIn) , Otto, Markus (VerfasserIn) , Wildemann, Brigitte (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 30 April 2025
In: Autoimmunity reviews
Year: 2025, Jahrgang: 24, Heft: 5, Pages: 1-11
ISSN:1873-0183
DOI:10.1016/j.autrev.2025.103765
Online-Zugang:Resolving-System, kostenfrei: https://doi.org/10.1016/j.autrev.2025.103765
Resolving-System, kostenfrei: https://doi.org/10.25673/118741
Volltext
Verfasserangaben:Franz F. Konen, Ulrich Wurster, Philipp Schwenkenbecher, Andreas Gerritzen, Catharina C. Groß, Peter Eichhorn, Andrea Harrer, Stefan Isenmann, Piotr Lewczuk, Jan Lewerenz, Frank Leypoldt, Markus Otto ... [und weitere]

MARC

LEADER 00000caa a2200000 c 4500
001 1919442251
003 DE-627
005 20250909115316.0
007 cr uuu---uuuuu
008 250310s2025 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.autrev.2025.103765  |2 doi 
024 7 |a 10.25673/118741  |2 doi 
035 |a (DE-627)1919442251 
035 |a (DE-599)KXP1919442251 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Konen, Franz Felix  |d 1995-  |e VerfasserIn  |0 (DE-588)1255045256  |0 (DE-627)1798102242  |4 aut 
245 1 0 |a Oligoclonal bands and kappa free light chains  |b Competing parameters or complementary biomarkers?  |c Franz F. Konen, Ulrich Wurster, Philipp Schwenkenbecher, Andreas Gerritzen, Catharina C. Groß, Peter Eichhorn, Andrea Harrer, Stefan Isenmann, Piotr Lewczuk, Jan Lewerenz, Frank Leypoldt, Markus Otto ... [und weitere] 
264 1 |c 30 April 2025 
300 |b Illustrationen, Diagramme 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar: 11. Februar 2025, Artikelversion: 18. Februar 2025 
520 |a Background: The 2024-revised McDonald criteria for multiple sclerosis (MS) proposed to incorporate cerebrospinal fluid (CSF)-specific oligoclonal bands and kappa free light chains (KFLC) as diagnostic biomarkers. While the 2017-revised criteria highlighted CSF-specific oligoclonal bands to indicate intrathecal IgG synthesis, significantly enhancing early MS diagnosis, KFLC have emerged as additional marker. Now, the question rises of whether both biomarkers serve as competing or complementary tools in MS diagnostics. Methods: In this narrative review, we extensively searched the literature on oligoclonal bands and KFLC determination in CSF and serum across neurological disorders, with a focus on MS, using the PubMed database to demonstrate the complementarity of both biomarkers. Results: Oligoclonal bands have long been a reliable marker of intrathecal IgG synthesis in MS, valued for their high diagnostic sensitivity, unique patient “fingerprints,” clonality differentiation, semi-quantitative analysis, and pre-analytic robustness. However, they present challenges in standardization, labor-intensity, method variability, examiner dependency, and limited data on non-IgG immunoglobulins. Quantitative KFLC measurement provides rapid, examiner-independent, and cost-effective assessment across all immunoglobulin classes but might have lower specificity, lacked consensus on standardized interpretation in recent years, and is not yet supported by comprehensive prospective multinational studies on its prognostic role. Conclusion: Both oligoclonal bands and KFLC have unique strengths and limitations that complement each other, potentially serving as complementary markers for evaluating intrathecal Ig synthesis in MS diagnosis. Further evidence is needed to establish the value of KFLC in MS diagnosis, thus multicenter prospective studies are being conducted to compare the diagnostic utility of both markers. 
540 |q DE-3  |a Namensnennung 4.0 International  |f CC BY 4.0  |2 cc  |u https://creativecommons.org/licenses/by/4.0/ 
700 1 |a Wurster, Ulrich  |e VerfasserIn  |4 aut 
700 1 |a Schwenkenbecher, Philipp  |d 1982-  |e VerfasserIn  |0 (DE-588)1070605131  |0 (DE-627)824963679  |0 (DE-576)43192547X  |4 aut 
700 1 |a Gerritzen, Andreas  |e VerfasserIn  |0 (DE-588)1290726698  |0 (DE-627)1846926866  |4 aut 
700 1 |a Groß, Catharina Christiane  |d 1973-  |e VerfasserIn  |0 (DE-588)130017892  |0 (DE-627)487574877  |0 (DE-576)297953591  |4 aut 
700 1 |a Eichhorn, Peter  |e VerfasserIn  |4 aut 
700 1 |a Harrer, Andrea  |e VerfasserIn  |0 (DE-588)1228169101  |0 (DE-627)1749509547  |4 aut 
700 1 |a Isenmann, Stefan  |d 1964-  |e VerfasserIn  |0 (DE-588)123094887  |0 (DE-627)706158423  |0 (DE-576)293552886  |4 aut 
700 1 |a Lewczuk, Piotr  |e VerfasserIn  |0 (DE-588)1283321831  |0 (DE-627)1839088842  |4 aut 
700 1 |a Lewerenz, Jan  |d 1971-  |e VerfasserIn  |0 (DE-588)12851471X  |0 (DE-627)373930399  |0 (DE-576)29718878X  |4 aut 
700 1 |a Leypoldt, Frank  |d 1976-  |e VerfasserIn  |0 (DE-588)129347795  |0 (DE-627)394260317  |0 (DE-576)297612670  |4 aut 
700 1 |a Otto, Markus  |e VerfasserIn  |0 (DE-588)1236714962  |0 (DE-627)1762502267  |4 aut 
700 1 |a Wildemann, Brigitte  |e VerfasserIn  |0 (DE-588)110203844  |0 (DE-627)510150004  |0 (DE-576)171831330  |4 aut 
773 0 8 |i Enthalten in  |t Autoimmunity reviews  |d Amsterdam [u.a.] : Elsevier Science, 2002  |g 24(2025), 5 vom: Apr., Artikel-ID 103765, Seite 1-11  |h Online-Ressource  |w (DE-627)360312071  |w (DE-600)2099325-0  |w (DE-576)260995614  |x 1873-0183  |7 nnas  |a Oligoclonal bands and kappa free light chains Competing parameters or complementary biomarkers? 
773 1 8 |g volume:24  |g year:2025  |g number:5  |g month:04  |g elocationid:103765  |g pages:1-11  |g extent:11  |a Oligoclonal bands and kappa free light chains Competing parameters or complementary biomarkers? 
856 4 0 |u https://doi.org/10.1016/j.autrev.2025.103765  |x Resolving-System  |z kostenfrei 
856 4 0 |u https://doi.org/10.25673/118741  |x Resolving-System  |z kostenfrei 
951 |a AR 
992 |a 20250909 
993 |a Article 
994 |a 2025 
998 |g 110203844  |a Wildemann, Brigitte  |m 110203844:Wildemann, Brigitte  |d 910000  |d 911100  |d 50000  |e 910000PW110203844  |e 911100PW110203844  |e 50000PW110203844  |k 0/910000/  |k 1/910000/911100/  |k 0/50000/  |p 20 
999 |a KXP-PPN1919442251  |e 4770371055 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1919442251","physDesc":[{"extent":"11 S.","noteIll":"Illustrationen, Diagramme"}],"origin":[{"dateIssuedDisp":"30 April 2025","dateIssuedKey":"2025"}],"relHost":[{"recId":"360312071","physDesc":[{"extent":"Online-Ressource"}],"disp":"Oligoclonal bands and kappa free light chains Competing parameters or complementary biomarkers?Autoimmunity reviews","pubHistory":["1.2002 -"],"origin":[{"publisher":"Elsevier Science","publisherPlace":"Amsterdam [u.a.]","dateIssuedKey":"2002","dateIssuedDisp":"2002-"}],"part":{"year":"2025","volume":"24","pages":"1-11","text":"24(2025), 5 vom: Apr., Artikel-ID 103765, Seite 1-11","extent":"11","issue":"5"},"title":[{"title_sort":"Autoimmunity reviews","title":"Autoimmunity reviews"}],"id":{"zdb":["2099325-0"],"eki":["360312071"],"issn":["1873-0183"]},"note":["Gesehen am 07.01.20"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"}}],"person":[{"display":"Konen, Franz Felix","role":"aut","given":"Franz Felix","family":"Konen"},{"role":"aut","given":"Ulrich","family":"Wurster","display":"Wurster, Ulrich"},{"display":"Schwenkenbecher, Philipp","role":"aut","given":"Philipp","family":"Schwenkenbecher"},{"role":"aut","given":"Andreas","family":"Gerritzen","display":"Gerritzen, Andreas"},{"display":"Groß, Catharina Christiane","family":"Groß","given":"Catharina Christiane","role":"aut"},{"family":"Eichhorn","given":"Peter","role":"aut","display":"Eichhorn, Peter"},{"family":"Harrer","given":"Andrea","role":"aut","display":"Harrer, Andrea"},{"display":"Isenmann, Stefan","role":"aut","given":"Stefan","family":"Isenmann"},{"display":"Lewczuk, Piotr","given":"Piotr","role":"aut","family":"Lewczuk"},{"display":"Lewerenz, Jan","role":"aut","given":"Jan","family":"Lewerenz"},{"family":"Leypoldt","given":"Frank","role":"aut","display":"Leypoldt, Frank"},{"given":"Markus","role":"aut","family":"Otto","display":"Otto, Markus"},{"display":"Wildemann, Brigitte","family":"Wildemann","role":"aut","given":"Brigitte"}],"title":[{"subtitle":"Competing parameters or complementary biomarkers?","title":"Oligoclonal bands and kappa free light chains","title_sort":"Oligoclonal bands and kappa free light chains"}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Online verfügbar: 11. Februar 2025, Artikelversion: 18. Februar 2025"],"name":{"displayForm":["Franz F. Konen, Ulrich Wurster, Philipp Schwenkenbecher, Andreas Gerritzen, Catharina C. Groß, Peter Eichhorn, Andrea Harrer, Stefan Isenmann, Piotr Lewczuk, Jan Lewerenz, Frank Leypoldt, Markus Otto ... [und weitere]"]},"id":{"eki":["1919442251"],"doi":["10.1016/j.autrev.2025.103765","10.25673/118741"]}} 
SRT |a KONENFRANZOLIGOCLONA3020